Xconomy

NOVEMBER 29, 2017

If Wednesday’s hearing for Health and Human Services Secretary Nominee Alex Azar is any indication, reining in drug prices and insurance premiums are the policy priorities that will guide Congress’s interaction with the department under a new leader. Read more » Reprints | Share: UNDERWRITERS AND PARTNERS.

Pricing 52

Pricing Guide Education Report 52

Xconomy

MAY 10, 2019

An April report from Evaluate Pharma predicted sales of orphan drugs to rise 12 percent a year between now and 2024, when they will account for an estimated 20 percent of worldwide prescription drug sales. The market for drugs for rare or “orphan” diseases continues to grow.

Pricing 97

Pricing Sales Competition Report 97

Xconomy

JANUARY 18, 2017

[Note: This report was co-authored by deputy biotech editor Ben Fidler.] Tom Price, the man who could oversee an overhaul of the U.S. Price, an orthopedic surgeon by training, is President-elect Donald Trump’s nominee for Health and Human Services Secretary.

Pricing 40

Pricing Training Report Services 40

Xconomy

APRIL 23, 2019

As public backlash against high drug prices shows no signs of waning, a private nonprofit in Boston, the Institute for Clinical Economic Review (ICER), has emerged as the country’s top drug-pricing watchdog. Read more » Reprints | Share: UNDERWRITERS AND PARTNERS.

Pricing 104

Pricing Report Funding San Diego 104

Xconomy

OCTOBER 27, 2016

Prices for agricultural commodities such as corn, soy, and wheat are at their lowest levels in years, but investment in agricultural technology has never been better. The increase in dollars flowing to agtech comes despite commodity prices that are down 65 percent from their 2013 peak, the report says.

Venture Capital 40

Venture Capital Pricing Invest Report 40

Xconomy

JANUARY 13, 2017

[ Editor’s note: Ben Fidler contributed to this report ] The week of frenetic data sharing, deal talking, and party hopping of the J.P. Morgan Healthcare Conference—and the events that have mushroomed around it—took a punch to the gut just as most attendees were wrapping up and checking their outbound flight status.

Pricing 40

Pricing Conference Press Report 40

Both Sides of the Table

OCTOBER 10, 2011

The big price increase : 5 out of 5 stars. Some customer segments value the DVD business and these may be more price sensitive. They might be willing to pay higher prices (and perhaps not an “all you can eat” price but a “pay as you go” price per film). A blog post! No, probably not.

Netflix 287

Netflix Customer Custom Pricing 287

Xconomy

OCTOBER 17, 2018

The pharmacy benefits manager (PBM) is excluding a new drug from Teva Pharmaceutical from coverage while favoring two rival treatments instead, according to a report from Reuters.

Report 67

Report Class Marketing San Diego 67

Xconomy

AUGUST 11, 2020

The larger company agreed to pay $12 per share for Pfenex (NYSE American: PFNX )—a 57 percent premium to its closing price Monday. The company reported revenues of about $120.3 million in 2019. In a prepared statement, Ligand CEO John Higgins called the Pfenex deal an “ideal strategic, business and cultural fit.”

San Diego 98

San Diego Technology Research Pricing 98

Xconomy

SEPTEMBER 9, 2016

The full report is here ; a summary is here.). Xconomy reached Tyler Jacks, the co-chair of the panel and director of the Koch Institute for Integrative Cancer Research at MIT, to ask about the report. Investors knocked about 30 percent off Dynavax’s share price last Friday, with only a modest recovery this week.

Pricing 40

Pricing Startup News Screening 40

Tech.Co

FEBRUARY 8, 2019

It reportedly paid a hefty $230 million to acquire the podcast publisher and network startup Gimlet Media, and has also acquired the podcast monetization platform Anchor for an undisclosed price. Today, blogging has been subsumed by the closed systems of social media. No one’s saying that now.

Acquisition 124

Acquisition Media News Platform 124

Xconomy

OCTOBER 28, 2016

THIS WEEK IN DRUG PRICING…. —A coalition of investors pressed drug makers to justify price increases. The group filed shareholder resolutions with 11 companies and cited a Kaiser Family Foundation poll that cited Americans’ concerns over drug prices. Alex Lash contributed to this report. billion last year.

Pricing 40

Pricing Conference News Study 40

Xconomy

FEBRUARY 8, 2019

26 hearing before the Senate Committee on Finance to defend their drug pricing practices. A group of top biopharma executives—the full roster isn’t known yet— will testify at a Feb.

Pricing 85

Pricing Report San Diego Company 85

Both Sides of the Table

MARCH 2, 2011

It’s apropos because there is so much noise these days with email, Twitter, Facebook, blogs, web shows, etc. I was thinking back to a few previous “insider baseball&# blog debates that raged for several weeks: AngelGate (aka Bin38 secret cabal), convertible debt vs. equity, bubble vs. not, and now the AngelList discussion.

Email 287

Email Blogging Venture Capital Writing 287

Xconomy

JULY 19, 2019

Soaring prices of Bitcoin and other so-called digital tokens were attracting investments from speculators hoping to get rich quick—but these virtual coin values were also known to drop just as suddenly, the US Treasury Department’s Financial Stability Oversight Council noted.

Pricing 89

Pricing Report Invest Venture Capital 89

Xconomy

JANUARY 22, 2018

Announcing the price on Jan. According to an independent report that came one week later, however, Spark’s concessions were marginal compared to a much bigger problem: The price is too high and should come down by at least 50 percent. The nonprofit Institute for Clinical and Economic Review’s report was perhaps.

Pricing 58

Pricing Report San Diego Blogging 58

Startup Professionals Musings

JULY 7, 2021

Today your reputation online is more important than your price, service, or location. Every reported problem likely means that many similar ones went unreported. You can remove items from your article or blog, but people do notice, and may escalate their concerns on another forum.

Social Media 144

Social Media Media Summary Satisfaction 144

Xconomy

OCTOBER 5, 2018

But since then its stock price has fallen significantly, dropping below $1 per share multiple times in the past two years, which nearly got the listing booted from the Nasdaq exchange. subsidiary, Firmenich—which reported about $3.3 Through a U.S. per share, or.

Pricing 81

Pricing Report Sales Company 81

Both Sides of the Table

AUGUST 14, 2017

I read commentary or Twitter or blogs and realize that there are also strongly held convictions that there are these evil VCs who do terrible things to mostly altruistic founders. But unlike the popular press reporting of this conflict — 80% of the time it is founder-to-founder conflict and not investor-to-founder conflict.

Startup 217

Startup Technical Review Equity Report 217

Xconomy

AUGUST 11, 2017

The FDA reported that generic drug approvals are set to hit a record ; the agency under Commissioner Scott Gottlieb has moved this summer to increase generic competition and lower the nation’s high drug prices. Meanwhile, drug-price hawks can sharpen their talons on a report this week from The New York Times and ProPublica.

Pricing 52

Pricing News Report Competition 52

Xconomy

APRIL 20, 2018

The price of drugs is certainly on a lot of minds these days, including the mind of President Trump, as he reportedly will make a. While pembrolizumab notched the headline-grabbing data, others are also working to develop options for various subsets of patients. Who will be able to afford all these options?

Pricing 52

Pricing News Report Develop 52

Xconomy

NOVEMBER 1, 2016

They’re also a controversial part of the national debate over high drug prices, and their increased use has put ophthalmologists in the crosshairs of insurers, the federal government, and the press. Drugs that treat a form of vision loss known as age related macular degeneration aren’t just big business.

Pricing 40

Pricing Press Services Report 40

Xconomy

APRIL 21, 2017

Our own reporting focused this week on the fallout from high drug prices, with a look at the frustration of families whose children have had trouble gaining access to the first drug ever approved for the rare spinal muscular atrophy. Earth Day’s—nationwide Marches for Science.

Study 49

Study News Pricing Google 49

Xconomy

JULY 11, 2019

Donald Trump’s criticism of high drug prices began during the 2016 presidential campaign and continued into his presidency, most famously when he said just before his inauguration that drug companies were “ getting away with murder.”

Pricing 81

Pricing Ideas San Diego Report 81

Xconomy

MAY 22, 2017

Last week, the other shoe dropped with reports that Ford will cut 10 percent of its global hourly workforce while holding on to the tech talent it has recruited in the past few years to work on electric and self-driving cars. When Donald Trump heralded Ford’s announcement earlier this year that it would invest $1.2

Report 55

Report Pricing Invest Artificial Inteligence 55

Xconomy

AUGUST 16, 2017

Private equity investors have more capital at their disposal than at any time in more than a decade, which could boost prices for companies seeking acquisitions. As of Aug. 1, private equity firms in North America and Europe had secured $212.6

Equity 69

Equity Pricing Acquisition Report 69

Both Sides of the Table

MAY 14, 2015

Well, if you choose the price, I choose the terms.” I’ve blogged for years. Here is from a great report by Fenwick & West. ” The report also notes that 75% of mega financings are led by non-VCs. .” “But if I don’t I won’t be able to recruit the best people in the market.

Startup 150

Startup Venture Capital Course Marketing 150

Xconomy

NOVEMBER 11, 2016

Drug company stocks got a boost with the defeat of Hillary Clinton, a vocal critic of drug prices. Will he take a softer stance on drug prices? But her near doubling of Trump (62 to 33 percent) didn’t translate into support for drug price controls. Now, the U.S. healthcare sector will try to figure out what it all means.

Patents 87

Patents Study Pricing Research 87

Xconomy

NOVEMBER 7, 2016

Xconomy reported Thursday that support for Proposition 61, the California initiative to rein in drug prices, had slipped in a recent poll to a slim 51 percent majority, with 24 percent opposed and 25 percent undecided. 61 would require state healthcare entities to pay drug prices equal to or less than those paid by the U.S.

Pricing 61

Pricing Startup Advertising Los Angeles 61

Xconomy

SEPTEMBER 29, 2017

After drug pricing, count drug shortages among the hot button issues sparking patient ire. Last year, the FDA says, 23 drug shortages were reported , down from 26 the previous year (and 251 in 2011). But Hurricane Maria’s direct strike on Puerto Rico might put the progress made on reducing shortages to the test.

Pricing 59

Pricing Report Sites San Diego 59

Xconomy

NOVEMBER 18, 2016

president’s intent to make good on his angry campaign rhetoric on drug prices, while the Associated Press reported that naming-and-shaming—that is, Congress hauling executives into hearings and penning angry letters—certainly hasn’t done the trick. Speculation swirled this week around the incoming U.S.

News 40

News Press Pricing Report 40

Xconomy

FEBRUARY 2, 2018

The San Diego-based early stage biotech, which specializes in RNA medicines, did not explain in a statement today why the Arcturus board decided to terminate Payne—only that his dismissal “is not related to Arcturus’ operational performance, ongoing programs, financial condition, or financial reporting.”

Arcturus 56

Arcturus San Diego Pricing Report 56

Xconomy

JULY 1, 2016

At the gathering, Biden took verbal shots at scofflaw cancer researchers and at drug prices, while the FDA said it would take a shot at restructuring the way it evaluates oncology products. Gilead Sciences has been a target of drug-price criticism for its hepatitis C treatments, but it dialed back the price of its new one.

Buzzfeed 59

Buzzfeed News Pricing IBM 59

Xconomy

JUNE 6, 2017

[ Note: Ben Fidler coauthored this report.] Drug costs remain a big worry, but there was no galvanizing moment like two years ago, when Leonard Saltz of the Memorial Sloan Kettering Cancer Center fired a broadside at the drug industry over the prices it. Read more » Reprints | Share: UNDERWRITERS AND PARTNERS.

Conference 59

Conference News Pricing Report 59

Xconomy

AUGUST 16, 2016

The industry can only go so far with growth through hyper-inflated pricing and mega-M&As. At some point pharma has to figure out how to make more drugs more efficiently, or face major dislocations like business-destroying price controls. The increasing need for new drugs is intense.

Product 40

Product Journal Venture Capital Demand 40

Xconomy

MARCH 12, 2018

The two companies had yet to even agree on a price in what was widely reported to represent the biggest tech deal in history. Singapore-based Broadcom had submitted bids ranging from. Read more » Reprints | Share:

Pricing 45

Pricing Report San Diego Company 45

Xconomy

NOVEMBER 3, 2016

We’re talking of course about next week’s vote on Proposition 61 in California, an attempt to control drug prices in the nation’s most populous state. This week, a poll released by the Hoover Institution and YouGov reported a slim majority of 51 percent in favor of Prop. While still positive for Prop. 61 passes.

Company 40

Company Companies Pricing Slides 40